Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Hospital, Ghent | OTHER |
| Vrije Universiteit Brussel | OTHER |
| Université de Liège | OTHER |
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to evaluate a community pharmacist intervention aimed at improving medication adherence in patients starting newly prescribed medication for cardiovascular disease prevention. The main questions it aims to answer are:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention arm | Experimental | Community pharmacist intervention |
|
| Control arm | No Intervention | Usual care |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| community pharmacist intervention | Behavioral | The community pharmacist intervention comprises 2 parts: (1) first prescription counseling (oral and written information), and (2) a follow-up consultation (by telephone or in person) 7-14 days later, to identify problems with adherence/treatment |
| Measure | Description | Time Frame |
|---|---|---|
| NIH Patient Reported Outcomes Measurement Information System (PROMIS) Medication Adherence Scale (PMAS) | Patient-reported measure of medication adherence | At 6 weeks and at 12 weeks follow-up |
| Measure | Description | Time Frame |
|---|---|---|
| Medication Possession Ratio (MPR) | Measure of medication adherence, using pharmacy refill records | Over 26 weeks post-baseline |
| Discontinuation rate | % of patients discontinuing the medication |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Els Mehuys | Contact | +32478509830 | els.mehuys@ugent.be | |
| Koen Boussery | Contact | +3292648043 | koen.boussery@ugent.be |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pharmaceutical Care Unit (Ghent University) | Recruiting | Ghent | Belgium |
Not provided
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
| D055118 | Medication Adherence |
| ID | Term |
|---|---|
| D010349 | Patient Compliance |
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Over 26 weeks post-baseline |
| Medication knowledge questionnaire | Questionnaire evaluating patient's basic knowledge about the medication | At 6 weeks and at 12 weeks follow-up |
| Beliefs about Medicines Questionnaire (BMQ-Specific) | Questionnaire evaluating patient's beliefs about the necessity of prescribed medication for controlling their illness (Specific-Necessity) and their concerns about the potential adverse consequences of taking it (Specific-Concerns) | At 6 weeks and at 12 weeks follow-up |
| Treatment response | Systolic and diastolic blood pressure for patients starting an antihypertensive drug; lipid levels (total cholesterol, LDL and HDL) for patients starting a lipid-lowering drug; HbA1c for patients starting an antidiabetic drug | At baseline and at 12 weeks follow-up |
| Healthcare utilization | Number of general practitioner (GP) visits, specialist-physician visits, emergency department (ED) visits and hospital admissions | Over 12 weeks post-baseline |
| D001519 | Behavior |